Idiopathic thrombocytopenic purpura surgery

Idiopathic thrombocytopenic purpura Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Idiopathic thrombocytopenic purpura from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Radiation
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Idiopathic thrombocytopenic purpura surgery On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Idiopathic thrombocytopenic purpura surgery All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Idiopathic thrombocytopenic purpura surgery
CDC on Idiopathic thrombocytopenic purpura surgery
Idiopathic thrombocytopenic purpura surgery in the news
Blogs on Idiopathic thrombocytopenic purpura surgery
Directions to Hospitals Treating Idiopathic thrombocytopenic purpura
Risk calculators and risk factors for Idiopathic thrombocytopenic purpura surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Surgery

Splenectomy is safe and effective in ~80% of patients with refractory HIV-related thrombocytopenia and treated with interferon (IFN) may be effective in refractory cases of patients coinfected with HCV. A decrease in platelets in HIV can arise secondary to both HCV and hepatitis B (HBV).